High Prevalence of Hepatitis B Virus Susceptibility Among Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

被引:0
|
作者
Kolli, Himabindu [1 ]
Patil, Rashmee [2 ]
机构
[1] UTRGV, Weslaco, TX USA
[2] South Texas Res Inst, Edinburg, TX USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S1388
引用
收藏
页码:S996 / S996
页数:1
相关论文
共 50 条
  • [31] The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
    Megahed, Fayed Attia Koutb
    Zhou, Xiaoling
    Sun, Pingnan
    Elmaghrabi, Marwa Mohamed
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01) : 1 - 11
  • [32] The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
    Fayed Attia Koutb Megahed
    Xiaoling Zhou
    Pingnan Sun
    Marwa Mohamed Elmaghrabi
    Egyptian Liver Journal, 11
  • [33] Impact of non-alcoholic fatty liver disease (NAFLD) on chronic hepatitis B (CHB) and C (CHC)
    Markova, A. A.
    Dragneva, S. S.
    Antonov, K.
    Jelev, D.
    Kosseva, O.
    Ivanova, R.
    Gegova, A.
    Mateva, L.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S355 - S355
  • [34] Prevalence of hepatitis B and C virus markers in non-alcoholic parenchymal liver disease
    Jain, AK
    Tyagi, R
    Tandon, A
    Dixit, VK
    Gupta, JP
    HEPATOLOGY, 1996, 23 (01) : P139 - P139
  • [35] Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity
    Mohamed, Rashdan Zaki
    Jalaludin, Muhammad Yazid
    Zaini, Azriyanti Anuar
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (02): : 247 - 253
  • [36] SARCOPENIA AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH ADVANCED FIBROSIS
    Golabi, Pegah
    Paik, James M.
    Cable, Rebecca
    Racila, Andrei
    Srishord, Manirath
    Younossi, Zobair M.
    HEPATOLOGY, 2021, 74 : 1039A - 1039A
  • [37] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    Current HIV/AIDS Reports, 2017, 14 : 47 - 53
  • [38] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [39] High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease
    Friis-Liby, I
    Aldenborg, F
    Jeristad, P
    Rundstörm, K
    Björnsson, E
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (09) : 864 - 869
  • [40] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53